---
title: "Taysha Gene Therapies, Inc. Stock 12‑Month Price Target Raised to $13, Implies 105% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291195276.md"
description: "Analysts have raised the average 12-month price target for Taysha Gene Therapies, Inc. to $13, up from $12.85, implying a 105% upside based on the June 26 closing price. The consensus rating remains 'Buy' across all 13 covering analysts, with no holds or sells."
datetime: "2026-06-29T22:20:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291195276.md)
  - [en](https://longbridge.com/en/news/291195276.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291195276.md)
---

# Taysha Gene Therapies, Inc. Stock 12‑Month Price Target Raised to $13, Implies 105% Upside

-   According to estimates from 13 analysts, Taysha Gene Therapies, Inc. stock's average price target has risen from $12.85 to $13, with forecasts ranging from $10 to $19 per share
-   Based on the Jun. 26 closing price, the updated target implies approximately 105% potential upside
-   Consensus rating remains at “Buy” across 13 covering analysts, with 13 Buys, 0 Holds and 0 Sells

Explore more price target data and ratings for Taysha Gene Therapies, Inc. on the , and track all previous and future analyst recommendations for Taysha Gene Therapies, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [TSHA.US](https://longbridge.com/en/quote/TSHA.US.md)

## Related News & Research

- [Taysha Gene Therapies taps Catalent for TSHA-102 Rett syndrome commercial manufacturing support](https://longbridge.com/en/news/294689795.md)
- [Boothe Investment Group Inc. Sells 13,044 Shares of Citigroup Inc. $C](https://longbridge.com/en/news/294473355.md)
- [J. Derek Lewis & Associates Inc. Sells 1,742 Shares of Tesla, Inc. $TSLA](https://longbridge.com/en/news/294497342.md)
- [FinArc Investments Inc. Buys Shares of 10,150 Amgen Inc. $AMGN](https://longbridge.com/en/news/294477934.md)
- [Front Street Capital Management Inc. Has $18.79 Million Position in Azenta, Inc. $AZTA](https://longbridge.com/en/news/294480762.md)